Lurain JR (December 2010). "Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole". American Journal of Obstetrics and Gynecology. 203 (6): 531–9. doi:10.1016/j.ajog.2010.06.073. PMID20728069.
Kohorn EI (2001). "The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment". International Journal of Gynecological Cancer. 11 (1): 73–7. doi:10.1046/j.1525-1438.2001.011001073.x. PMID11285037.
Lipata F, Parkash V, Talmor M, Bell S, Chen S, Maric V, Hui P (April 2010). "Precise DNA genotyping diagnosis of hydatidiform mole". Obstetrics and Gynecology. 115 (4): 784–94. doi:10.1097/AOG.0b013e3181d489ec. PMID20308840. S2CID41305866.
Alifrangis C, Seckl MJ (December 2010). "Genetics of gestational trophoblastic neoplasia: an update for the clinician". Future Oncology. 6 (12): 1915–23. doi:10.2217/fon.10.153. PMID21142864.
Azuma C, Saji F, Tokugawa Y, Kimura T, Nobunaga T, Takemura M, Kameda T, Tanizawa O (January 1991). "Application of gene amplification by polymerase chain reaction to genetic analysis of molar mitochondrial DNA: the detection of anuclear empty ovum as the cause of complete mole". Gynecologic Oncology. 40 (1): 29–33. doi:10.1016/0090-8258(91)90080-O. PMID1671219.
Sebire NJ (2010). "Histopathological diagnosis of hydatidiform mole: contemporary features and clinical implications". Fetal and Pediatric Pathology. 29 (1): 1–16. doi:10.3109/15513810903266138. PMID20055560. S2CID21384533.
Chalouhi GE, Golfier F, Soignon P, Massardier J, Guastalla JP, Trillet-Lenoir V, Schott AM, Raudrant D (June 2009). "Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicity". American Journal of Obstetrics and Gynecology. 200 (6): 643.e1–6. doi:10.1016/j.ajog.2009.03.011. PMID19393597.
Abrão RA, de Andrade JM, Tiezzi DG, Marana HR, Candido dos Reis FJ, Clagnan WS (January 2008). "Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactinomycin and combination regimens". Gynecologic Oncology. 108 (1): 149–53. doi:10.1016/j.ygyno.2007.09.006. PMID17931696.
Kang WD, Choi HS, Kim SM (June 2010). "Weekly methotrexate (50mg/m(2)) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasia". Gynecologic Oncology. 117 (3): 477–80. doi:10.1016/j.ygyno.2010.02.029. PMID20347479.
FIGO Committee on Gynecologic Oncology (April 2009). "Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia". International Journal of Gynaecology and Obstetrics. 105 (1): 3–4. doi:10.1016/j.ijgo.2008.12.015. PMID19322933. S2CID41395844.
Lok CA, Ansink AC, Grootfaam D, van der Velden J, Verheijen RH, ten Kate-Booij MJ (November 2006). "Treatment and prognosis of post term choriocarcinoma in The Netherlands". Gynecologic Oncology. 103 (2): 698–702. doi:10.1016/j.ygyno.2006.05.011. PMID16790263.
Wolfberg AJ, Feltmate C, Goldstein DP, Berkowitz RS, Lieberman E (September 2004). "Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy". Obstetrics and Gynecology. 104 (3): 551–4. doi:10.1097/01.AOG.0000136099.21216.45. PMID15339768. S2CID1172620.
van Trommel NE, Massuger LF, Verheijen RH, Sweep FC, Thomas CM (October 2005). "The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey". Gynecologic Oncology. 99 (1): 6–13. doi:10.1016/j.ygyno.2005.06.032. PMID16085294.
Suri S, Davies M, Jauniaux E (2009). "Twin pregnancy presenting as a praevia complete hydatidiform mole and coexisting fetus complicated by a placental abscess". Fetal Diagnosis and Therapy. 26 (4): 181–4. doi:10.1159/000253272. PMID19864876. S2CID7720159.
Dolapcioglu K, Gungoren A, Hakverdi S, Hakverdi AU, Egilmez E (March 2009). "Twin pregnancy with a complete hydatidiform mole and co-existent live fetus: two case reports and review of the literature". Archives of Gynecology and Obstetrics. 279 (3): 431–6. doi:10.1007/s00404-008-0737-x. PMID18679699. S2CID20825878.
Vandenhove M, Amant F, van Schoubroeck D, Cannie M, Dymarkowski S, Hanssens M (May 2008). "Complete hydatidiform mole with co-existing healthy fetus: a case report". The Journal of Maternal-Fetal & Neonatal Medicine. 21 (5): 341–4. doi:10.1080/14767050801925156. PMID18446663. S2CID6552298.
True DK, Thomsett M, Liley H, Chitturi S, Cincotta R, Morton A, Cotterill A (September 2007). "Twin pregnancy with a coexisting hydatiform mole and liveborn infant: complicated by maternal hyperthyroidism and neonatal hypothyroidism". Journal of Paediatrics and Child Health. 43 (9): 646–8. doi:10.1111/j.1440-1754.2007.01145.x. PMID17688651. S2CID45319678.
Behtash N, Behnamfar F, Hamedi B, Ramezanzadeh F (April 2009). "Term delivery following successful treatment of choriocarcinoma with brain metastases, a case report and review of literature". Archives of Gynecology and Obstetrics. 279 (4): 579–81. doi:10.1007/s00404-008-0753-x. PMID18726607. S2CID24481680.
Ganapathi KA, Paczos T, George MD, Goodloe S, Balos LL, Chen F (September 2010). "Incidental finding of placental choriocarcinoma after an uncomplicated term pregnancy: a case report with review of the literature". International Journal of Gynecological Pathology. 29 (5): 476–8. doi:10.1097/PGP.0b013e3181d81cc2. PMID20736774.
Altieri A, Franceschi S, Ferlay J, Smith J, La Vecchia C (November 2003). "Epidemiology and aetiology of gestational trophoblastic diseases". The Lancet. Oncology. 4 (11): 670–8. doi:10.1016/S1470-2045(03)01245-2. PMID14602247.
Berkowitz RS, Cramer DW, Bernstein MR, Cassells S, Driscoll SG, Goldstein DP (August 1985). "Risk factors for complete molar pregnancy from a case-control study". American Journal of Obstetrics and Gynecology. 152 (8): 1016–20. doi:10.1016/0002-9378(85)90550-2. PMID4025447.
Lurain JR (December 2010). "Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole". American Journal of Obstetrics and Gynecology. 203 (6): 531–9. doi:10.1016/j.ajog.2010.06.073. PMID20728069.
Kohorn EI (June 2002). "Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia. A progress report". The Journal of Reproductive Medicine. 47 (6): 445–50. PMID12092012.
Kohorn EI (2001). "The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment". International Journal of Gynecological Cancer. 11 (1): 73–7. doi:10.1046/j.1525-1438.2001.011001073.x. PMID11285037.
Lipata F, Parkash V, Talmor M, Bell S, Chen S, Maric V, Hui P (April 2010). "Precise DNA genotyping diagnosis of hydatidiform mole". Obstetrics and Gynecology. 115 (4): 784–94. doi:10.1097/AOG.0b013e3181d489ec. PMID20308840. S2CID41305866.
Alifrangis C, Seckl MJ (December 2010). "Genetics of gestational trophoblastic neoplasia: an update for the clinician". Future Oncology. 6 (12): 1915–23. doi:10.2217/fon.10.153. PMID21142864.
Azuma C, Saji F, Tokugawa Y, Kimura T, Nobunaga T, Takemura M, Kameda T, Tanizawa O (January 1991). "Application of gene amplification by polymerase chain reaction to genetic analysis of molar mitochondrial DNA: the detection of anuclear empty ovum as the cause of complete mole". Gynecologic Oncology. 40 (1): 29–33. doi:10.1016/0090-8258(91)90080-O. PMID1671219.
Sebire NJ (2010). "Histopathological diagnosis of hydatidiform mole: contemporary features and clinical implications". Fetal and Pediatric Pathology. 29 (1): 1–16. doi:10.3109/15513810903266138. PMID20055560. S2CID21384533.
Chalouhi GE, Golfier F, Soignon P, Massardier J, Guastalla JP, Trillet-Lenoir V, Schott AM, Raudrant D (June 2009). "Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicity". American Journal of Obstetrics and Gynecology. 200 (6): 643.e1–6. doi:10.1016/j.ajog.2009.03.011. PMID19393597.
Abrão RA, de Andrade JM, Tiezzi DG, Marana HR, Candido dos Reis FJ, Clagnan WS (January 2008). "Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactinomycin and combination regimens". Gynecologic Oncology. 108 (1): 149–53. doi:10.1016/j.ygyno.2007.09.006. PMID17931696.
Kang WD, Choi HS, Kim SM (June 2010). "Weekly methotrexate (50mg/m(2)) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasia". Gynecologic Oncology. 117 (3): 477–80. doi:10.1016/j.ygyno.2010.02.029. PMID20347479.
Lurain JR, Singh DK, Schink JC (October 2006). "Role of surgery in the management of high-risk gestational trophoblastic neoplasia". The Journal of Reproductive Medicine. 51 (10): 773–6. PMID17086805.
FIGO Committee on Gynecologic Oncology (April 2009). "Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia". International Journal of Gynaecology and Obstetrics. 105 (1): 3–4. doi:10.1016/j.ijgo.2008.12.015. PMID19322933. S2CID41395844.
Izhar R (2003). "Prognosis of gestational choriocarcinoma at Khyber Teaching Hospital Peshawar". Journal of Ayub Medical College, Abbottabad. 15 (2): 45–8. PMID14552249.
Yang JJ, Xiang Y, Wan XR, Yang XY (August 2008). "Prognosis of malignant gestational trophoblastic neoplasia: 20 years of experience". The Journal of Reproductive Medicine. 53 (8): 600–7. PMID18773625.
Lok CA, Ansink AC, Grootfaam D, van der Velden J, Verheijen RH, ten Kate-Booij MJ (November 2006). "Treatment and prognosis of post term choriocarcinoma in The Netherlands". Gynecologic Oncology. 103 (2): 698–702. doi:10.1016/j.ygyno.2006.05.011. PMID16790263.
Wolfberg AJ, Feltmate C, Goldstein DP, Berkowitz RS, Lieberman E (September 2004). "Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy". Obstetrics and Gynecology. 104 (3): 551–4. doi:10.1097/01.AOG.0000136099.21216.45. PMID15339768. S2CID1172620.
Garrett LA, Garner EI, Feltmate CM, Goldstein DP, Berkowitz RS (July 2008). "Subsequent pregnancy outcomes in patients with molar pregnancy and persistent gestational trophoblastic neoplasia". The Journal of Reproductive Medicine. 53 (7): 481–6. PMID18720922.
van Trommel NE, Massuger LF, Verheijen RH, Sweep FC, Thomas CM (October 2005). "The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey". Gynecologic Oncology. 99 (1): 6–13. doi:10.1016/j.ygyno.2005.06.032. PMID16085294.
Suri S, Davies M, Jauniaux E (2009). "Twin pregnancy presenting as a praevia complete hydatidiform mole and coexisting fetus complicated by a placental abscess". Fetal Diagnosis and Therapy. 26 (4): 181–4. doi:10.1159/000253272. PMID19864876. S2CID7720159.
Dolapcioglu K, Gungoren A, Hakverdi S, Hakverdi AU, Egilmez E (March 2009). "Twin pregnancy with a complete hydatidiform mole and co-existent live fetus: two case reports and review of the literature". Archives of Gynecology and Obstetrics. 279 (3): 431–6. doi:10.1007/s00404-008-0737-x. PMID18679699. S2CID20825878.
Vandenhove M, Amant F, van Schoubroeck D, Cannie M, Dymarkowski S, Hanssens M (May 2008). "Complete hydatidiform mole with co-existing healthy fetus: a case report". The Journal of Maternal-Fetal & Neonatal Medicine. 21 (5): 341–4. doi:10.1080/14767050801925156. PMID18446663. S2CID6552298.
True DK, Thomsett M, Liley H, Chitturi S, Cincotta R, Morton A, Cotterill A (September 2007). "Twin pregnancy with a coexisting hydatiform mole and liveborn infant: complicated by maternal hyperthyroidism and neonatal hypothyroidism". Journal of Paediatrics and Child Health. 43 (9): 646–8. doi:10.1111/j.1440-1754.2007.01145.x. PMID17688651. S2CID45319678.
Behtash N, Behnamfar F, Hamedi B, Ramezanzadeh F (April 2009). "Term delivery following successful treatment of choriocarcinoma with brain metastases, a case report and review of literature". Archives of Gynecology and Obstetrics. 279 (4): 579–81. doi:10.1007/s00404-008-0753-x. PMID18726607. S2CID24481680.
Ganapathi KA, Paczos T, George MD, Goodloe S, Balos LL, Chen F (September 2010). "Incidental finding of placental choriocarcinoma after an uncomplicated term pregnancy: a case report with review of the literature". International Journal of Gynecological Pathology. 29 (5): 476–8. doi:10.1097/PGP.0b013e3181d81cc2. PMID20736774.
Altieri A, Franceschi S, Ferlay J, Smith J, La Vecchia C (November 2003). "Epidemiology and aetiology of gestational trophoblastic diseases". The Lancet. Oncology. 4 (11): 670–8. doi:10.1016/S1470-2045(03)01245-2. PMID14602247.
Savage P, Williams J, Wong SL, Short D, Casalboni S, Catalano K, Seckl M (2010). "The demographics of molar pregnancies in England and Wales from 2000-2009". The Journal of Reproductive Medicine. 55 (7–8): 341–5. PMID20795349.
Soares PD, Maestá I, Costa OL, Charry RC, Dias A, Rudge MV (2010). "Geographical distribution and demographic characteristics of gestational trophoblastic disease". The Journal of Reproductive Medicine. 55 (7–8): 305–10. PMID20795343.
Chauhan A, Dave K, Desai A, Mankad M, Patel S, Dave P (2010). "High-risk gestational trophoblastic neoplasia at Gujarat Cancer and Research Institute: thirteen years of experience". The Journal of Reproductive Medicine. 55 (7–8): 333–40. PMID20795348.
Kashanian M, Baradaran HR, Teimoori N (October 2009). "Risk factors for complete molar pregnancy: a study in Iran". The Journal of Reproductive Medicine. 54 (10): 621–4. PMID20677481.
Berkowitz RS, Cramer DW, Bernstein MR, Cassells S, Driscoll SG, Goldstein DP (August 1985). "Risk factors for complete molar pregnancy from a case-control study". American Journal of Obstetrics and Gynecology. 152 (8): 1016–20. doi:10.1016/0002-9378(85)90550-2. PMID4025447.
Palmer JR (March 1994). "Advances in the epidemiology of gestational trophoblastic disease". The Journal of Reproductive Medicine. 39 (3): 155–62. PMID8035370.
FIGO Committee on Gynecologic Oncology (April 2009). "Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia". International Journal of Gynaecology and Obstetrics. 105 (1): 3–4. doi:10.1016/j.ijgo.2008.12.015. PMID19322933. S2CID41395844.
Suri S, Davies M, Jauniaux E (2009). "Twin pregnancy presenting as a praevia complete hydatidiform mole and coexisting fetus complicated by a placental abscess". Fetal Diagnosis and Therapy. 26 (4): 181–4. doi:10.1159/000253272. PMID19864876. S2CID7720159.
Dolapcioglu K, Gungoren A, Hakverdi S, Hakverdi AU, Egilmez E (March 2009). "Twin pregnancy with a complete hydatidiform mole and co-existent live fetus: two case reports and review of the literature". Archives of Gynecology and Obstetrics. 279 (3): 431–6. doi:10.1007/s00404-008-0737-x. PMID18679699. S2CID20825878.
Vandenhove M, Amant F, van Schoubroeck D, Cannie M, Dymarkowski S, Hanssens M (May 2008). "Complete hydatidiform mole with co-existing healthy fetus: a case report". The Journal of Maternal-Fetal & Neonatal Medicine. 21 (5): 341–4. doi:10.1080/14767050801925156. PMID18446663. S2CID6552298.
True DK, Thomsett M, Liley H, Chitturi S, Cincotta R, Morton A, Cotterill A (September 2007). "Twin pregnancy with a coexisting hydatiform mole and liveborn infant: complicated by maternal hyperthyroidism and neonatal hypothyroidism". Journal of Paediatrics and Child Health. 43 (9): 646–8. doi:10.1111/j.1440-1754.2007.01145.x. PMID17688651. S2CID45319678.
Behtash N, Behnamfar F, Hamedi B, Ramezanzadeh F (April 2009). "Term delivery following successful treatment of choriocarcinoma with brain metastases, a case report and review of literature". Archives of Gynecology and Obstetrics. 279 (4): 579–81. doi:10.1007/s00404-008-0753-x. PMID18726607. S2CID24481680.
